Citadel Advisors »

Lyra Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $128k 20k 6.59

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Lyra Therapeutics

Perceptive Advisors
Sabby Management
Ikarian Capital
Citadel Advisors
DRW Holdings
Geode Capital Management
Artia Global Partners
BlackRock
Tower Research Capital
Royal Bank of Canada
UBS Group
FMR
EverSource Wealth Advisors
Jones Financial Companies, L.L
SBI Securities

View all funds holding Lyra Therapeutics